Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention

Anil Desphande, Donald D. Muccio, Craig D. Smith et al.|Bioorganic & Medicinal Chemistry|2013

Cited by 22